Responsabilità del produttore di farmaci e dovere di informativa, tra “tutela consumeristica” e art. 2050 c.c.

Federico Piaia

Responsabilità del produttore di farmaci e dovere di informativa, tra “tutela consumeristica” e art. 2050 c.c.

Translated title of the contribution: Responsibility of the drug manufacturer and duty of information, between “consumer protection” and art. 2050 of the Italian Civil Code

Federico Piaia

Research output: Contribution to journal › Article

Abstract

Ruling on the issue of damage resulting from the taking of a drug, the Supreme Court of Cassation judges settle the dispute using the regulations on producer’s responsibility in Leg. Dec. September 6, 2005, n. 206 (“Consumer Code”), in light of the main dictates offered over time by the case law, then focusing, in particular, on the role of (medicinal) product information.

Translated title of the contribution	Responsibility of the drug manufacturer and duty of information, between “consumer protection” and art. 2050 of the Italian Civil Code
Original language	Italian
Pages (from-to)	719-730
Number of pages	12
Journal	DANNO E RESPONSABILITÀ
Volume	2021
Issue number	6
Publication status	Published - 2021

Keywords

Prodotto difettoso
codice del consumo
responsabilità della casa farmaceutica
tutela del consumatore

Cite this

@article{d92049bd97234a179797e0af75ace77a,

title = "Responsabilit{\`a} del produttore di farmaci e dovere di informativa, tra “tutela consumeristica” e art. 2050 c.c.",

abstract = "Ruling on the issue of damage resulting from the taking of a drug, the Supreme Court of Cassation judges settle the dispute using the regulations on producer{\textquoteright}s responsibility in Leg. Dec. September 6, 2005, n. 206 (“Consumer Code”), in light of the main dictates offered over time by the case law, then focusing, in particular, on the role of (medicinal) product information.",

keywords = "Prodotto difettoso, codice del consumo, responsabilit{\`a} della casa farmaceutica, tutela del consumatore, Prodotto difettoso, codice del consumo, responsabilit{\`a} della casa farmaceutica, tutela del consumatore",

author = "Federico Piaia",

year = "2021",

language = "Italian",

volume = "2021",

pages = "719--730",

journal = "DANNO E RESPONSABILIT{\`A}",

issn = "1125-8918",

publisher = "IPSOA: Istituto postuniversitario per lo studio dell'organizzazione aziendale.",

number = "6",

}

TY - JOUR

T1 - Responsabilità del produttore di farmaci e dovere di informativa, tra “tutela consumeristica” e art. 2050 c.c.

AU - Piaia, Federico

PY - 2021

Y1 - 2021

N2 - Ruling on the issue of damage resulting from the taking of a drug, the Supreme Court of Cassation judges settle the dispute using the regulations on producer’s responsibility in Leg. Dec. September 6, 2005, n. 206 (“Consumer Code”), in light of the main dictates offered over time by the case law, then focusing, in particular, on the role of (medicinal) product information.

AB - Ruling on the issue of damage resulting from the taking of a drug, the Supreme Court of Cassation judges settle the dispute using the regulations on producer’s responsibility in Leg. Dec. September 6, 2005, n. 206 (“Consumer Code”), in light of the main dictates offered over time by the case law, then focusing, in particular, on the role of (medicinal) product information.

KW - Prodotto difettoso

KW - codice del consumo

KW - responsabilità della casa farmaceutica

KW - tutela del consumatore

KW - Prodotto difettoso

KW - codice del consumo

KW - responsabilità della casa farmaceutica

KW - tutela del consumatore

UR - https://publicatt.unicatt.it/handle/10807/231047

M3 - Articolo

SN - 1125-8918

VL - 2021

SP - 719

EP - 730

JO - DANNO E RESPONSABILITÀ

JF - DANNO E RESPONSABILITÀ

IS - 6

ER -

Responsabilità del produttore di farmaci e dovere di informativa, tra “tutela consumeristica” e art. 2050 c.c.

Abstract

Keywords

Other files and links

Fingerprint

Cite this